Silvina Pugliese, M.D., is a Clinical Assistant Professor of Dermatology and Attending Physician at the Stanford Medicine Outpatient Center and Stanford Cancer Institute. She attended medical school at Boston University and completed her residency at Loma Linda, serving as Chief Resident in her final year. Dr. Pugliese practices Supportive Dermato-Oncology (SDO) at the Stanford main campus and also launched the South Bay Cancer Center's SDO Clinic in 2015. She is interested in the management of cutaneous complications associated with chemotherapy, radiation therapy, organ transplantation, and their impact on patient quality of life.
Sumaira Z. Aasi, M.D., is a Professor of Dermatology and Director of Mohs and Dermatologic Surgery. Dr. Aasi completed a fellowship in Mohs micrographic surgery and cutaneous oncology at Yale University where she was on faculty and served as Associate Chief. Dr. Aasi helped train fellows in Mohs and Micrographic Surgery for over ten years. She has served on the Board of Directors of the American College of Mohs Surgery. Her clinical interests include management of high risk nonmelanoma skin cancers, Mohs histopathology, and reconstructive surgery.
University Position: Assistant Professor
Current Appointments: Attending Staff, Kingston Health Sciences Centre
Areas of Clinical Interest: Cleft Lip and Palate, Oncological Reconstruction, Plastic Surgery
Areas of Research Interest: Melanoma, Healthcare Economics
Fellowship: 2008-09 — Cleft and Pediatric Craniofacial Surgery, Royal Children's Hospital, Melbourne Australia
My mission is to provide the highest standards of care in prevention, diagnosis and treatment of gynecologic cancers by incorporating the latest surgical approaches and practicing evidence based medicine. My practice promotes compassionate care with a focus on empowering women to be active participants in decision making regarding their health care, which ultimately allows them to make appropriate treatment choices.
University of Tennessee College of Medicine, MD
University of South Florida College of Medicine, Tampa, FL, Internship & Residency, Obstetrics and Gynecology
H. Lee Moffitt Cancer Center, Tampa, FL, Fellowship, Gynecologic Oncology
Areas of Expertise
Dr. Hoffman is a world-renowned expert in the surgical management of gynecologic cancers and other complex gynecologic disorders. He has over 30 years of surgical experience, has published extensively on all aspects of female cancer surgery, and has lectured around the world on these subjects. Dr. Hoffman’s expertise includes laparoscopic, robotic, open (traditional) and vaginal surgery. After completing his gynecologic oncology fellowship at The University of South Florida, Dr. Hoffman stayed as a full-time faculty member until October of 2015. He is the author of one textbook, over 250 articles in scientific journals and 24 textbook chapters. He is an examiner for the American Board of Obstetrics and Gynecology. Dr. Hoffman was voted by physician peers as one of the top gynecologic oncologists (Tampa Magazine, 2017).
In addition to his clinical practice, Dr. Gupta is an accomplished researcher. He has studied treatments for lymphoma and carcinoma; his research has appeared in the American Journal of Physiology, American Pediatric Society Journal, and American Society of Clinical Oncology Journal; and he is the author a medical book published by the University of Zambia Press.
Dr. Nick is a board certified gynecologic oncologist. Dr. Nick received her medical degree from Louisiana State University Health Sciences Center, and completed her gynecologic oncology fellowship at the University of Texas MD Anderson Cancer Center in Houston, TX in 2011. As a gynecologic oncologist at MD Anderson Cancer Center, Dr. Nick worked collaboratively to expand the developmental therapeutics research program and led a quality improvement project focused on improving outcomes and standardizing care for patients with ovarian cancer. Dr. Nick provides patients who are high risk or have gynecologic cancers novel and up-to-date medical and surgical treatment options including laparoscopic and robotic surgery.
I am a board-certified gynecologic oncologist who specializes in surgery for women with ovarian, endometrial, cervical, vulvar, or vaginal cancer.
I have a strong interest in providing minimally invasive surgical options for our patients, including both laparoscopic and robotic-assisted procedures. In 2006, I became one of the first gynecologic oncologists to use the da Vinci® Surgical System to perform robotically-assisted procedures in women with benign and malignant gynecologic conditions. Minimally invasive procedures result in less blood loss than do traditional surgeries, allowing for shorter hospital stays and faster recuperation time for patients. I serve as the Director for the Minimal Access and Robotic Surgery Program in the Department of Surgery at Memorial Sloan Kettering and have helped to build one of the best and most experienced robotic surgery programs in the world across multiple surgical specialties.
I also perform radical procedures via traditional laparotomy in cases when these more-traditional surgeries may provide better results and longer survival. These include debulking for ovarian cancer and radical procedures for other gynecologic cancers.
Dr. Edward Tanner is an assistant professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics and at Johns Hopkins Bayview Medical Center. He serves as the director of surgical innovations and the robotic surgery program in the department, leader of the Kelly Gynecologic Oncology Service’s Sentinel Lymph Node Program, and associate director of the F.J. Montz Fellowship Program in Gynecologic Oncology.
Additionally, Dr. Tanner is co-leader of the GYN/Urology Comprehensive Unit-based Safety Program and the Robotic Surgery Steering Committee. In these roles, he oversees a multidisciplinary program in surgical quality and patient safety at the hospital. Dr. Tanner is recognized for his outstanding surgical skills, compassionate bedside manner and teaching abilities.
Dr. Tanner’s clinical interests include the surgical management of advanced gynecologic cancers, including radical debulking surgery for ovarian cancer, as well as minimally invasive surgery for early-stage female cancers.
Evan J. Lipson, M.D., is a medical oncologist at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology at Johns Hopkins University School of Medicine. Dr. Lipson established the Johns Hopkins Melanoma Program at Sibley in 2012 and opened the program's first clinical trial in the Washington, D.C. region in 2015. He is board certified in internal medicine and medical oncology.
Dr. Lipson has an expertise in melanoma and treatment of patients with cutaneous malignancies, specifically regarding the use of novel immunotherapies.
My practice is dedicated to the comprehensive care and treatment of women diagnosed with gynecologic cancers, pre-cancerous conditions and complex problems that require the specialized training and experience of a gynecologic oncologist.
It is the mission of our doctors, nurses and other support personnel to provide the best treatments available to all of our patients, while at the same time recognizing that each patient is a partner in their own treatment. We therefore strive to provide the highest level of care in an atmosphere that promotes the open exchange of information between the patient and the caregiver.
Even though the nature of medical care delivery changes daily, we will always work hard to maintain the high standard of patient care that has been a distinguishing feature of our practice since its beginning in 1998.
In practice since: 1992
Paola A. Gehrig, MD, is a UNC Lineberger Comprehensive Cancer Center member and Professor and Director of UNC Gynecologic Oncology within the Department of Obstetrics and Gynecology at UNC-Chapel Hill.
My clinical interests include gynecologic oncology, surgery in gynecologic malignancies, and complicated gynecologic surgery.
My research interests include a range of clinical/translational research focused on women's cancers.
Dr. Cragun is an assistant professor at the University of Arizona. She specializes in the diagnosis and treatment of gynecologic cancers such as endometrial and ovarian cancers as well as rare reproductive cancers, abnormal pap smears, high-risk cancer screening and fertility preservation.
Before completing the gynecologic oncology fellowship program at the University of South Florida in Tampa, Dr. Cragun earned her medical degree at the University of Utah School of Medicine, Salt Lake City, Utah; completed a residency in obstetrics and gynecology at Duke University Medical Center, Durham, North Carolina, and pursued a post-doctoral research fellowship at H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.
Currently, gynecologic cancers account for about 12 percent of all cancers which affect US women.
Dr. Master is a Professor of Urology at the Emory University School of Medicine, Associate Chair for Clinical Affairs and Quality, and Director of Clinical Research Unit.
Following his undergraduate education at Northwestern University, Dr. Master attended medical school at the University of Chicago where he received both MD and PhD degrees. He completed his urology residency and two fellowships training at the University of California in San Francisco (UCSF) before joining the Department of Urology at Emory University in 2005. Dr. Master is a diplomate of the American Board of Urology (2006) a Fellow of the American College of Surgery (FACS).
Dr. Master’s primary clinical interest is urologic oncology, in particular kidney cancer, adrenal tumors, testicular cancer, high-risk prostate cancer and penile cancers. Dr. Master is a renowned national expert in the surgical treatment of kidney cancer particularly a complex variety that extends into the main blood vessels and the heart. He also has a special interest in minimally invasive laparoscopic technique that removes of cancerous lymph nodes with minimal interference with the patients’ quality of life.
Lance C. Pagliaro, M.D., conducts research in kidney, prostate, bladder, testicular and penile cancers. Dr. Pagliaro specializes in the medical treatment of these conditions using immuno-oncology drugs and other targeted therapies.
Dr. Pagliaro is interested in how molecularly targeted drugs and immune checkpoint inhibitors can be combined for the treatment of advanced renal cell carcinoma and prostate cancer. He also studies novel drug combinations for the treatment of metastatic bladder cancer.
Robert G. Mennel, M.D. specializes in medical oncology and hematology with board certification in both internal medicine and medical oncology. He is a Diplomate of the American Board of Internal Medicine with subspecialty certification in medical oncology.
Dr. Mennel received an M.D. from the University of Pennsylvania Medical School in 1970. He completed training in internal medicine at the University of Rochester, Strong Memorial Hospital, in 1974, and a fellowship in hematology and oncology at Johns Hopkins Oncology Center in 1979.